[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account
arrow_back Bone Strengtheners
Zoledronic acid (Zometa®)
Administration: iv

How it Works

In multiple myeloma, osteoclasts (cells that break down bone) are overactive, so more bone is destroyed faster than new bone can be created. Osteoclasts can cause lesions that weaken the bone and lead to complications. Some of the complications resulting from this bone breakdown are bone pain, fractures, and, less commonly, hypercalcemia (increased levels of calcium in the blood). Zometa slows osteoclast activity.


How it’s Administered

A healthcare provider will administer this injection by infusion into a vein (>15 minutes).


Who Should Take Zometa

Zometa is currently approved for:

  • Patients who have high calcium levels in the blood 
  • Patients with multiple myeloma or other types of cancer have affected the bones

Who Shouldn’t Take Zometa

  • Patients with hypersensitivity to Zometa
  • Patients with severe kidney problems 
  • Patients who are pregnant 
  • Patients with low calcium blood levels

The Most Common Side Effects of Taking Zometa Include: 

  • Bone pain
  • Nausea 
  • Mild fever
  • Fatigue
  • Anemia
  • Vomiting
  • Constipation
  • Flu-like symptoms

Learn more about your treatments in Cure Hub

Information provided by www.dynamed.com and www.uptodate.com
All About Bisphosphonate Therapy: Zometa (Zoledronic Acid) or Aredia (Pamidronate)
newsletter icon

Get the latest thought leadership on your Primary Mediastinal B-Cell Lymphoma delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.

Thanks to our HealthTree Community for Primary Mediastinal B-Cell Lymphoma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Genentech
Regeneron
Adaptive